NO792398L - Anvendelse av sarkosin og sarkosinderivater som tumorhemmende bestanddeler, og fremgangsmaate ved fremstillinhg av disse - Google Patents

Anvendelse av sarkosin og sarkosinderivater som tumorhemmende bestanddeler, og fremgangsmaate ved fremstillinhg av disse

Info

Publication number
NO792398L
NO792398L NO792398A NO792398A NO792398L NO 792398 L NO792398 L NO 792398L NO 792398 A NO792398 A NO 792398A NO 792398 A NO792398 A NO 792398A NO 792398 L NO792398 L NO 792398L
Authority
NO
Norway
Prior art keywords
sarcosine
tumor
combination
anhydride
series
Prior art date
Application number
NO792398A
Other languages
English (en)
Norwegian (no)
Inventor
Hans Osswald
Mahmoud Youssef
Original Assignee
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch
Publication of NO792398L publication Critical patent/NO792398L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO792398A 1978-07-20 1979-07-19 Anvendelse av sarkosin og sarkosinderivater som tumorhemmende bestanddeler, og fremgangsmaate ved fremstillinhg av disse NO792398L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782832009 DE2832009A1 (de) 1978-07-20 1978-07-20 Verwendung von sarkosin und sarkosinderivaten ls tumorhemmende wirksubstanzen

Publications (1)

Publication Number Publication Date
NO792398L true NO792398L (no) 1980-01-22

Family

ID=6044955

Family Applications (1)

Application Number Title Priority Date Filing Date
NO792398A NO792398L (no) 1978-07-20 1979-07-19 Anvendelse av sarkosin og sarkosinderivater som tumorhemmende bestanddeler, og fremgangsmaate ved fremstillinhg av disse

Country Status (13)

Country Link
US (1) US4766149A (enExample)
EP (1) EP0007597B1 (enExample)
JP (1) JPS5519270A (enExample)
AT (1) ATE11220T1 (enExample)
AU (1) AU529657B2 (enExample)
CA (1) CA1151065A (enExample)
DD (1) DD144864A5 (enExample)
DE (1) DE2832009A1 (enExample)
DK (1) DK305479A (enExample)
FI (1) FI792218A7 (enExample)
MC (1) MC1271A1 (enExample)
NO (1) NO792398L (enExample)
ZA (1) ZA793603B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010599A1 (de) 1979-03-22 1980-10-09 Continental Pharma Derivate von glycinamid, deren herstellung und verwendung
DE3440090A1 (de) * 1984-11-02 1986-05-07 Novo-Med AG, Appenzell Aminosaeureloesungen enthaltendes arzneimittel zur therapie von krebserkrankungen und verfahren zu seiner herstellung
US4916217A (en) * 1987-01-08 1990-04-10 Bristol-Myers Company Phosphorus containing derivatives of epipodophyllotoxin
US4994492A (en) * 1989-01-09 1991-02-19 Foodscience Corporation Treatment of melanoma using N,N-dimethylglycine
US5676978A (en) * 1989-02-14 1997-10-14 Amira, Inc. Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent
IT1229203B (it) * 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
DE4026184A1 (de) * 1990-08-18 1992-02-20 Henkel Kgaa Verfahren zur verminderung des restgehaltes an freiem alkylierungsmittel in waessrigen loesungen kationischer tenside
CN100469361C (zh) * 2002-06-19 2009-03-18 纽迪希亚公司 治疗或预防哺乳动物遭受代谢作用压力时的分解代谢或刺激性合成代谢的方法及组合物
US8697679B2 (en) * 2003-03-07 2014-04-15 N.V. Nutricia Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
EP1847274A1 (en) * 2006-04-21 2007-10-24 CIPROSA LLC - Corporate Creations Network, Inc. Association of phenylbutyrate, ATRA and cytidine and its use in anti-tumour therapy
EP3415910A1 (en) 2017-06-16 2018-12-19 Prevention Medicals s.r.o. A method of quantitative determination of sarcosine in a biological sample using anti-arcosine antibodies and peroxidase-active gold nanoparticles or quantum dots

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE553424C (de) * 1928-04-18 1932-06-27 Karl Luedecke Dr Verfahren zur Herstellung von Praeparaten, die das Wachstum von Geweben durch Verminderung der Teilungsfaehigkeit oder Aufloesung der wuchernden Zellen einschraenken
BE647556A (enExample) * 1964-05-06 1964-08-31
FR2085637A1 (fr) * 1970-04-15 1971-12-31 Etude Des Catalyseurs Soc D Composition pharmaceutique utilisable notamment contre l'asthenie
DE2211019C3 (de) * 1972-03-08 1980-08-28 Bayer Ag, 5090 Leverkusen Geschmacksverbessernde Formulierungen oraler Penicilline

Also Published As

Publication number Publication date
CA1151065A (en) 1983-08-02
EP0007597B1 (de) 1985-01-16
JPS5519270A (en) 1980-02-09
AU4907679A (en) 1980-01-24
MC1271A1 (fr) 1980-05-23
EP0007597A1 (de) 1980-02-06
AU529657B2 (en) 1983-06-16
ATE11220T1 (de) 1985-02-15
ZA793603B (en) 1980-07-30
DK305479A (da) 1980-01-21
DE2832009A1 (de) 1980-01-31
FI792218A7 (fi) 1981-01-01
US4766149A (en) 1988-08-23
DD144864A5 (de) 1980-11-12
DE2832009C2 (enExample) 1988-07-28

Similar Documents

Publication Publication Date Title
Creighton et al. Antitumour activity in a series of bis diketopiperazines
DE2556100C2 (enExample)
AU2009210356B2 (en) Formulations and methods of administration of cephalotaxines, including homoharringtonine
JPH05503914A (ja) 細胞増殖の抑制及びｎｋ細胞活性の増強
AU727524B2 (en) Creatine pyruvates and a method of producing them
JPS5843996A (ja) 安定なｓ−アデノシルメチオニン塩、それらの製造法及び活性成分としてこれらを含む治療組成物
EA004179B1 (ru) Способ лечения неопластического заболевания при введении фенилацетилглутамина, фенилацетилизоглутамина и/или фенилацетата
US4160826A (en) Inhibitor preparation for the absorption of lipids, based on diethylaminoethyldextran
AT395111B (de) Verfahren zur herstellung von infusionsloesungen zur pareuteralen ernaehrung
NO324974B1 (no) Anvendelse av 3-amino-1,2,4-benzotriazin-1,4-dioksyd/paclitaxel/platina for fremstilling av et preparat for behandling av et pattedyr som har en fast tumor samt kit inneholdende nevnte preparat.
EP0007597B1 (de) N-Niedrigalkylglycinamide und Sarkosinanhydrid sowie in Kombination mit bekannten tumorhemmenden Verbindungen vorliegendes Sarkosin zur Anwendung bei der Heilung von Tumoren sowie dieselben enthaltendes Mittel und Verfahren zu dessen Herstellung
Baldini et al. Antineoplastic activity of diazoacetyl-glycine derivatives
CA2435921A1 (en) Method of cancer therapy
FI78069C (fi) Foerfarande foer framstaellning av saosom laekemedel anvaendbara acylerade enamidfoereningar.
US3179562A (en) Treatment of diabetes with alpha, alpha substituted acetic acid derivatives
HU180443B (en) Process for preparing a pharmaceutical preparation with synergetic action against radiation
US4686215A (en) Pharmaceutical composition and method for treating tumors susceptible to 2-carbamoylaziridine
US3067242A (en) Di-(n, n-dimethyloctadecylamine) pamoate
RU2663836C1 (ru) L-Энантиомер 2-этил-6-метил-3-гидроксипиридиния гидроксибутандиоата, обладающий церебропротекторной активностью
IE49181B1 (en) Treatment of malignancies by administering sarcosine,its derivatives and mixtures
RU2066192C1 (ru) Радиопротекторное средство
KR102028383B1 (ko) 난청의 예방 또는 치료용 조성물
US3317391A (en) Composition for treatment of angina pectoris and process for preparing same
US3755567A (en) Method for treating alcoholism
KR920002792B1 (ko) 아실화 엔아미드 화합물의 제조 방법